Ultresa
Active Ingredient(s): PancrelipaseFDA Approved: * March 1, 2012
Pharm Company: * APTALIS PHARMA US
Category: Enzymes
Pancreatic enzymes, also known as pancreases or pancrelipase and pancreatin, are commercial mixtures of amylase, lipase, and protease.[1][2] They are used to treat malabsorption syndrome due to certain pancreatic problems.[1] These pancreatic problems may be due to cystic fibrosis, surgical removal of the pancreas, long term pancreatitis, or pancreatic cancer, among others.[1][3] The preparation is taken by mouth.... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.Dosage List
Ultresa (Amylases 27,600 Unt / Lipase 13,800 Unt / Proteases 27,600 Unt) Delayed Release Capsule
NDC: 58914-003
Labeler:
Aptalis Pharma Us, Inc
Ultresa (Amylases 46,000 Unt / Lipase 23,000 Unt / Proteases 46,000 Unt) Delayed Release Capsule
NDC: 58914-005
Labeler:
Aptalis Pharma Us, Inc
Ultresa (Amylases 41,400 Unt / Lipase 20,700 Unt / Proteases 41,400 Unt) Delayed Release Capsule
NDC: 58914-019
Labeler:
Aptalis Pharma Us, Inc
Related Brands
Drugs with the same active ingredients